
IP News
The $2.25 Billion mRNA Landmark: Analyzing the Moderna-Arbutus LNP Patent Settlement
Moderna settles its long-standing LNP patent dispute with Arbutus and Genevant for a record-breaking $2.25 billion, setting a new benchmark for mRNA platform technology licensing.










